In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...

Genome-editing technologies, particularly CRISPR-based systems, have rapidly advanced from experimental tools to platforms with broad applications across ...

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

Explore the differences between BTech Bioengineering and BSBE in 2026. Compare core subjects, laboratory focus, and career ...

Zoom stock is still far below Cathie Wood’s $1,500 ARK forecast for 2026. See what happened since 2022. Learn more here.

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

PHD2-haplodeficient macrophages (MØs) are promising candidates for the treatment of ischemia-related conditions due to their capacity to modulate the ischemic microenvironment. However, their in vitro ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...

Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...

Cathie Wood has made a name for herself as an innovation-focused growth investor, and her leadership as the founder and CEO ...